Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01458587 · ClinicalTrials.gov registry record · Phase 2
Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)
A Phase 2 study, sponsored by DUSA Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 70
- Enrollment target
NCT01458587 is a Phase 2 study that has completed, run by DUSA Pharmaceuticals. The registered enrollment target is 70 participants.
The verdict
NCT01458587, a Phase 2 study, has completed, sponsored by DUSA Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if Levulan PDT is safe and effective in the treatment of actinic keratoses on the upper arms and hands.
Interventions
- DRUG Aminolevulinic Acid PDT (ALA)
- DRUG Vehicle PDT (VEH)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2011-11 |
| Est. Completion | 2012-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01458587
The ClinicalTrials.gov registry entry for NCT01458587 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DUSA Pharmaceuticals, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Aminolevulinic Acid PDT (ALA) is the first listed.
NCT01458587 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01458587 about?
NCT01458587 is a clinical study titled "Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)". The purpose of this study is to determine if Levulan PDT is safe and effective in the treatment of actinic keratoses on the upper arms and hands.
What is the current status of trial NCT01458587?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 70 participants. The study started on 2011-11. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01458587?
The interventions under investigation include: Aminolevulinic Acid PDT (ALA) (DRUG), Vehicle PDT (VEH) (DRUG).
Who is sponsoring clinical trial NCT01458587?
This trial is sponsored by DUSA Pharmaceuticals, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.